Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Windtree Therapeutics Inc (NASDAQ: WINT) closed at $0.90 down -11.76% from its previous closing price of $1.02. In other words, the price has decreased by -$11.76 from its previous closing price. On the day, 1.53 million shares were traded.
Ratios:
For a deeper understanding of Windtree Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.45 and its Current Ratio is at 0.45. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on June 26, 2020, initiated with a Buy rating and assigned the stock a target price of $12.25.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 08 ’24 when Fraser Craig bought 5,431 shares for $0.91 per share. The transaction valued at 4,942 led to the insider holds 8,638 shares of the business.
Stock Price History:
Over the past 52 weeks, WINT has reached a high of $737.43, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -45.62%, while the 200-Day Moving Average is calculated to be -99.08%.
Shares Statistics:
A total of 0.75M shares are outstanding, with a floating share count of 0.75M. Insiders hold about 0.13% of the company’s shares, while institutions hold 0.84% stake in the company.
